IP Library › Granted Patent US 9,662,515
Granted Patent B2
US 9,662,515 · App. 14/239,398 · Granted May 30, 2017

Method for producing 4-aminobutyric acid from algae

Inventors: Tim Köhler (Dorsten, DE); Jennifer Schild (Solingen, DE); Matthias Mentel (Dortmund, DE); Peter Lersch (Dinslaken, DE); Mike Farwick (Essen, DE); Christian Weitemeyer (Seeburg, DE)
Assignee: EVONIK DEGUSSA GMBH
A61Q19/007A61K8/44A61K8/99A61K36/04A61Q5/00A61Q5/12A61Q17/04A61Q19/002A61Q19/004A61Q19/06A61Q19/08C12P13/005A61Q5/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,662,515
App. No.
14/239,398
Granted
May 30, 2017
Kind
B2
Abstract

The invention relates to a process for the production of 4-aminobutyric acid, also referred to as gamma-aminobutyric acid, in short GABA, to a process for the production of an extract comprising 4-aminobutyric acid, to a process for the preparation of a cosmetic formulation comprising 4-aminobutyric acid, and to the use of Cyanidium caldarium cells or cell components in cosmetic applications.

Claims (5)

1. A process for the production of 4-aminobutyric acid, comprising: culturing Cyanidium caldarium cells containing 4-aminobutyric acid in an aqueous medium; disrupting the Cyanidium caldarium cells to obtain solid cell components containing said 4-aminobutyric acid; and incorporating the disrupted Cyanidium caldarium cells comprising solid cell components containing said 4-aminobutryic acid in a cosmetic formulation.

2. The process according to claim 1 , wherein said Cyanidium caldarium cells are cultured at a temperature from 20° C. to 60° C.

3. The process according to claim 1 , wherein said culturing provides an aqueous medium having a pH at 25° C. of from 1.5 to 6.

4. The process according claim 1 , wherein said disrupting the Cyanidium caldarium cells is performed in an aqueous medium.

5. The process according to claim 1 , wherein said disrupting the Cyanidium caldarium cells comprises a hot-water disruption in combination with an enzymatic cell disruption.

Assignments (2)
CHANGE OF NAME Recorded Apr 16, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 052422/0342 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2014
From: KOHLER, TIM; SCHILD, JENNIFER; MENTEL, MATTHIAS; LERSCH, PETER; FARWICK, MIKE; WEITEMEYER, CHRISTIAN
To: EVONIK DEGUSSA GMBH
Reel/Frame 033286/0144 →
Priority Claims (1)
DE 10 2011 110 996 · Aug 18, 2011 · national
Continuity (1)
Related Publication 20140308310A1 · Oct 16, 2014